CODI-PB — Compass Diversified

Summary of CODI-PB Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 GAAP Net Revenue: $468.6 million, down 5.1% year-over-year, primarily due to the impact of Lugano's bankruptcy.
• Q4 2025 GAAP Net Loss: $78.8 million, including over $25 million in one-time costs related to Lugano.
• Full Year 2025 Net Revenues: $1.9 billion, up 4.8%.
• Full Year 2025 GAAP Net Loss: $293.7 million, which includes approximately $60 million in investigation and restatement-related expenses.
• Non-GAAP Results (excluding Lugano):
  • Net Sales: $1.8 billion, up 3.9%.
  • Subsidiary Adjusted EBITDA: $345.8 million, an increase of 8.8%.
  • Consumer Adjusted EBITDA: up 13.8%; Industrial Adjusted EBITDA: up 1.1%.
• Leverage Ratio: Approximately 5.47x at year-end, slightly higher than anticipated.
• Cash Position: $68 million in cash and equivalents, with $96 million available on the revolver.

2. Strategic Updates and Business Highlights

• Operational Resilience: Despite a challenging year, CODI's subsidiaries demonstrated strong performance, with mid-single-digit revenue growth and high single-digit adjusted EBITDA growth.
• Focus on Deleveraging: CODI's primary strategic initiative is to reduce its leverage ratio through organic growth and potential divestitures.
• Subsidiary Performance:
  • BOA: Successful presence at the 2026 Winter Games, indicating strong brand performance.
  • The Honey Pot: Established a leading position in feminine care, showing strong consumer metrics and growth potential.
  • Arnold: Experienced a backlog increase of over 40% year-over-year, positioned well for growth in aerospace and defense despite geopolitical challenges.
• Divestiture Plans: Multiple sale processes are underway for subsidiaries to improve financial flexibility and shareholder value.

3. Forward Guidance and Outlook

• 2026 Subsidiary Adjusted EBITDA Guidance: Expected to be between $345 million and $395 million, reflecting mid-single-digit growth.
• Consumer Adjusted EBITDA: Projected between $220 million to $260 million; Industrial Adjusted EBITDA between $125 million to $135 million.
• Capital Expenditures: Expected to be between $30 million to $40 million.
• Free Cash Flow: Anticipated to be between $50 million and $100 million.

4. Bad News, Challenges, or Points of Concern

• Impact of Lugano: The bankruptcy and associated costs have significantly affected financial results.
• Geopolitical Risks: Ongoing trade tensions and tariff uncertainties are creating volatility, particularly affecting the industrial segment, specifically Arnold.
• Consumer Behavior: Inflation and tariffs have negatively impacted consumer spending, leading to a cautious outlook for branded consumer businesses.
• Weakness in Altor: The industrial business is facing headwinds due to reduced government spending on vaccines and tariffs affecting appliance purchases.

5. Notable Q&A Insights

• Sale Processes: Strong interest in the subsidiaries being considered for divestiture, with multiple bidders expected.
• Arnold's Outlook: While facing near-term challenges, Arnold is expected to see growth as it laps previous export controls and benefits from increased quoting activity.
• Altor's Caution: The outlook remains cautious due to ongoing challenges in the vaccine market and tariffs affecting demand.
• 5.11 Performance: The professional side is stable, but the consumer side faces challenges due to inflation and price sensitivity.
• Leverage Targets: Long-term target of 3x to 3.5x leverage, with an expectation to reach around 4x by the end of 2026, primarily through divestitures and organic growth.

Overall, CODI-PB is navigating a challenging environment with a focus on deleveraging and strategic growth, while managing the impacts of external economic factors and internal operational challenges.